Gelesis is a biotherapeutics company advancing a novel hydrogel platform technology to treat obesity, help with weight management, and other chronic metabolic diseases.
Gelesis became a publicly listed company on January 14, 2022 after completing a business combination with Capstar Special Purpose Acquisition Corp, a publicly traded special purpose acquisition company. Forge no longer actively tracks this company.
